The present invention relates generally to devices for measurements of tissue perfusion according to the preamble of independent claim 1 and more particularly to a sensor for measurement of tissue perfusion over a given variable region and having a short response time.
Tissue perfusion is a measure of the amount (volume) of blood passing through a unit quantity of the tissue and is often measured with the unit ml blood/100 g tissue. Since all blood tissues are at the same time being supplied with nutrients and excrete waste products through diffusion between tissue cells and the blood, tissue perfusion is a very important factor indicating the state of health of a tissue. A method for the measurement of tissue perfusion is therefore highly pertinent, for instance for monitoring tissue during and after surgical operations and transplantations. Monitoring of potentially threatened tissue, e.g. muscular tissue, whose blood supply may become adversely affected by increasing pressure in the connective tissue membrane of the muscle, would be highly pertinent as an indication of when a pressure relieving operation should be initiated. Likewise monitoring of internal perfusion caused by the formation of oedemas in a heart stopped during operation could provide valuable information about the need of external supply of nutrients to the tissue of the heart. Within medical research, perfusion is an important parameter too.
A number of methods for determination of tissue perfusion are known. A technique consisting of an injection into the relevant tissue of radioactive xenon as a tracer and measuring the decay of radioactivity as a function of time has been described (see Larsen et al., 1966. Blood Flow through Human Adipose Tissue Determined with Radioactive Xenon. Acta physiol. scand. 66, pp 337–345), but this technique suffers from a number of drawbacks in that its temporal resolution only amounts to approximately half an hour which is insufficient in many situations. Furthermore the location of the injection of the radioactive matter into the tissue relative to the location where the radioactivity is being measured is not particularly well-defined and finally, the application of radioactive matter per se involves potential hazards.
Another method of measuring tissue perfusion utilises continuous injection of ethanol during microdialysis. During microdialysis a fluid is being pumped very slowly through a fibre inserted into the tissue of the patient. The concentration of the fluid is in equilibrium with the surrounding tissue as the catheter is diffusion-open and the fluid is being collected via a return fibre. This method also suffers from an insufficient temporal resolution.
WO 97/46853 discloses a method and a microsensor which is able to measure tissue perfusion. The sensor comprises a tracer-permeable insert placed in a mouth of a tracer reservoir confined by a container, whereby said insert forms a permeable wall portion of the reservoir. A sensoric tip of a transducer is placed inside the insert or immediately outside of the latter. From the specification as a whole it appears that the tip of the transducer is very small, a diameter of 2 μm being mentioned. Consequently the transducer detects or measures the tracer concentration or pressure in a single point or in an extremely limited area. This also applies, if the transducer is provided with an inner cylindrical cavity, which is closed by the permeable insert or by a separate membrane forming the end wall of the transducer.
In connection with monitoring tissue perfusion for instance during surgical operations, the above-mentioned prior art suffers from the drawbacks of either insufficient temporal resolution or a very limited measurement space.
In order to circumvent the drawbacks and limitations of methods and devices for the measurement of tissue perfusion of prior art as mentioned above, it is the object of the present invention to provide a device (sensor) for the measurement of tissue perfusion which is able to integrate measurements of tissue perfusion over a larger region in the tissue, the dimensions of which region can be varied as desired.
It is a further object of the present invention to provide a device with a response time not exceeding a few minutes.
It is a further object of the present invention to provide at least one embodiment of the general inventive idea which makes it possible to carry out non-invasive measurements of skin perfusion or measurements of prefusion in the surface layers of an organ, for instance for assessment of insufficient blood circulation.
These objects are accomplished with a device (sensor) according to the characterising clause of claim 1.
Various advantageous embodiments of the invention are defined in the dependent claims.
In the sensor for tissue perfusion according to the invention a fluid or gaseous tracer from a suitable supply means is supplied to a reservoir in which a constant high concentration of the tracer is maintained through diffusion from the supply means and from which reservoir a small portion of the tracer molecules will diffuse into a tracer-permeable barrier which is partly in contact with the surrounding tissue. From this barrier, part of the tracer molecules will move out into the surrounding tissue via a first spatially extended area, whereas another portion of the tracer molecules will move into an adjoining detector cavity via a second spatially extended area, said detector cavity being in communication with a suitable detector apparatus measuring the concentration of tracer in the detection cavity. The movement of tracer molecules from the reservoir into the surrounding tissue thus takes place via a tracer-permeable barrier which is in contact with the surrounding tissue via said first spatially extended area and the portion of the tracer molecules moving into the detection cavity arrives at the detection cavity via a tracer-permeable barrier and said second spatially extended area. Said first area thus constitutes the area of contact between said tracer-permeable barrier and the surrounding tissue, whose perfusion is to be measured, whereas said second area constitutes the area through which tracer molecules are able to reach the detection cavity. The distribution between the diffusion to the surrounding tissue and the diffusion to the detection cavity will be determined by the flow of dissolve matter in the surrounding tissue, i.e. the perfusion, such that if the transport in the tissue is of large magnitude only a small portion of the tracer will diffuse into the detection cavity and vice versa. The signal from the detection apparatus will thus become a measure of tissue perfusion in the region surrounding the fibre.
According to the present invention the dimensions of the contact region between said tracer-permeable barrier and the surrounding tissue can be varied and thereby the region over which the tissue perfusion measurement is being carried out. It is also possible to vary the second area providing access to the detection cavity. By varying the geometry of the sensor, i.e. the relative layout of the reservoir, barrier and detection cavity, it is possible to vary the sensitivity and the radial resolution of the measurements being performed. It is furthermore possible to utilise a mixture of at least two tracers which might be supplied and removed substantially momentarily. A time-based measurement after instantaneous supply/removal to/from the tracer reservoir of two tracers with different diffusion coefficients will make it possible to distinguish between how much of the diffusion of the tracers away from the tracer reservoir is due to the concentration gradient within the tissue and how much is due to the transportation of the tracers away from the tissue by the blood. Thus, independent measures of perfusion and of diffusion coefficients within the tissue can be obtained.
It is furthermore possible to carry out measurements of O2 and CO2 and other gasses present in the tissue simultaneously with tissue perfusion.
As a suitable tracer for tissue perfusion measurements for instance helium, argon or hydrogen could be used, but it would also be possible to use other tracers.
Finally for in-situ calibration purposes the patient can inhale a gas which is being detected by the sensor placed in the tissue.
The invention will now be described by way of exemplifying embodiments hereof and with reference to the accompanying drawings in which
a is a longitudinal section of a first embodiment of a sensor according to the present invention;
b is a cross section along the line indicated by A—A in
a is a longitudinal section of a second embodiment of a sensor according to the present invention;
b is a cross section along the line indicated by B—B in
a is a side elevation cross-sectional view of a first version of a fourth embodiment of the present invention;
b is a side elevation cross-sectional view of a second version of a fourth embodiment of the present invention;
a is a side elevation cross-sectional view of a first version of a fifth embodiment of the present invention comprising interlaced reservoir- and detection cavity sections;
b is a side elevation cross-sectional view of a second version of a fifth embodiment of the present invention comprising interlaced reservoir- and detection cavity sections;
In the following detailed part of the present description a number of different embodiments of the present invention will be described with reference to the accompanying drawings, but it is understood that these embodiments only constitute examples of the general inventive idea, and that other embodiments may be conceivable by a person skilled in the art.
The first embodiment of the sensor is shown in
The fibre is designed to be positioned within the tissue of a patient whose perfusion in that part of the tissue is to be measured. The functional principle of the invention is that a constantly high concentration of the tracer is maintained in the reservoir 4, the concentration being maintained via diffusion from the supply container. A small portion of the molecules of the tracer will due to diffusion move from the reservoir 4 out into the gas-permeable barrier 3 and a portion hereof will move out into the surrounding tissue through a first area 18, as indicated by the arrows 9, while another portion will move into the detection cavity 5 through a second area 13, as indicated by the arrows 10, and eventually be detected by means of the detection apparatus. The distribution between the diffusion to the surrounding tissue and the diffusion to the detection cavity 5 will be determined by the transport of dissolved matter in the surrounding tissue, such that if the transport in the tissue is of a large magnitude only a small portion of the tracer will diffuse into the detection cavity 5 and vice versa. The signal from the detection apparatus will thus become a measure of tissue perfusion in the region surrounding the fibre.
a and
The fibre is designed to be positioned within the tissue of a patient whose perfusion in that part of the tissue is to be measured. The functional principle of the invention is that a constantly high concentration of the tracer is maintained in the reservoir 4, the concentration being maintained via diffusion from the supply container. A small portion of the molecules of the tracer will due to diffusion move from the reservoir 4 out through the wall of the reservoir tube 14 through a first area 14′ (as delimited by the two arrows C in
A third embodiment (not shown) of the present invention is directly derivable from the two first embodiments described above in that the structures shown in
a and 3b show a fourth embodiment of the present invention which differs significantly from the three previous embodiments described above. Where the three above embodiments were designed to be inserted into the tissue, the fourth embodiment of the present invention is fastened non-invasively on the surface (20) of the skin or of an organ of a patient to provide the possibility of carrying out measurements of perfusion in the surface layers of the skin or the organ such as carried out for the assessment of insufficient blood circulation in for instance a leg of the patient.
The operational principle of the first version of the fourth embodiment shown in
In the embodiment shown in
In the embodiment shown in
A more preferable variation of the embodiments shown in
In the embodiments of the present invention according to
Above, a number of different embodiments of the present invention have been shown and described, but it is understood that these embodiments only constitute examples of the general inventive idea as defined in the accompanying claims, and that other embodiments of the present invention might be conceivable by a person skilled in the art.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/DK99/00522 | 10/4/1999 | WO | 00 | 7/1/2002 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO01/24692 | 4/12/2001 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
RE30317 | Lubbers et al. | Jul 1980 | E |
5594179 | Marsh | Jan 1997 | A |
6234004 | Revsbech et al. | May 2001 | B1 |
Number | Date | Country |
---|---|---|
0549394 | Jun 1993 | EP |
0549394 | Jun 1993 | EP |
0747675 | Dec 1996 | EP |
9516392 | Jun 1995 | WO |
PCTUS9413243 | Jun 1995 | WO |
9719345 | May 1997 | WO |
PCTDK9600488 | May 1997 | WO |
9746853 | Dec 1997 | WO |
PCTDK9700250 | Dec 1997 | WO |
98 59240 | Dec 1998 | WO |
PCTGB9801783 | Dec 1998 | WO |